Dr. Andrew Charles Krakowski, MD

Dr. Krakowski practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Krakowski's NPI, 1962651679, was assigned on September 17, 2008. Dr. Krakowski holds Pennsylvania license MD457574.

Dr. Krakowski's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Krakowski's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Krakowski is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Krakowski to 2 more physician offices, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krakowski practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Krakowski's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Krakowski's licenses on file in 3 states: Pennsylvania, California and New Jersey.

CMS data shows 294 Medicare services from Dr. Krakowski across 8 procedure codes in 2024, for 134 Medicare patients. Medicare paid $16,754 for them. Every service was in an office.

CMS counts 134 Medicare patients who saw Dr. Krakowski in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Krakowski's median patient age at 65, with 49% women.

In 2024, Dr. Krakowski wrote 57 Medicare Part D claims for 14 patients. 72% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $296 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Krakowski for performance year 2024, reported through an alternative payment model (APM). Dr. Krakowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of skin biopsy by Dr. Krakowski, more than 62% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 54 papers to Dr. Krakowski, published from 2014 to 2025. 2015 was the busiest year, with 7. The most frequent topics are Laser Therapy, Acne Vulgaris and Lasers, Dye. Dr. Krakowski has published most often in Pediatr Dermatol. Dr. Krakowski's most frequent co-authors are Peter Randall Shumaker, MD, Stephanie Feldstein, MD and Lawrence F. Eichenfield, MD.

CMS Open Payments shows 35 general payments to Dr. Krakowski from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $230.